2025 annual financial data
Cumberland Pharmaceuticals 2025 Operating cash flow
Direct answer
Operating cash flow was 4,932,522 USD.
Operating income was -2,791,993 USD and net income was -2,836,128 USD.
Operating cash flow was 4,932,522 USD.
Get free Cumberland Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 44,521,431 USD
- Operating income
- -2,791,993 USD
- Net income
- -2,836,128 USD
- Operating cash flow
- 4,932,522 USD